Results 11 to 20 of about 147,672 (267)

Case of hereditary papillary renal cell carcinoma [PDF]

Journal of Community Hospital Internal Medicine Perspectives, 2012
Renal cell carcinoma is the most common type of renal malignancy and it originates from the renal tubular epithelium. Due to the diversity in the histopathological and molecular characteristics, it is typically subclassified into five different ...
Sadaf Mustafa, Nima Jadidi, Sheila F. Faraj, Ronald Rodriguez   +3 more
doaj   +5 more sources

PD-L1 expression in papillary renal cell carcinoma

BMC Urology, 2017
BackgroundThe immune escape or tolerance of cancer cells is considered to be closely involved in cancer progression. Programmed death-1 (PD-1) is an inhibitory receptor expressed on activating T cells, and several types of cancer cells were found to ...
Takanobu Motoshima, Yoshihiro Komohara, Chaoya Ma, Arni Kusuma Dewi, Hirotsugu Noguchi, Sohsuke Yamada, Toshiyuki Nakayama, Shohei Kitada, Yoshiaki Kawano, Wataru Takahashi, Masaaki Sugimoto, Motohiro Takeya, Naohiro Fujimoto, Yoshinao Oda, Masatoshi Eto   +14 more
semanticscholar   +5 more sources

Clear Cell Papillary Renal Cell Carcinoma. [PDF]

Archives of Pathology & Laboratory Medicine, 2019
Clear cell papillary renal cell carcinoma (ccpRCC) is a recently recognized entity and represents the fourth most common variant of renal cell carcinoma (RCC).
Jianping Zhao, E. Eyzaguirre
semanticscholar   +6 more sources

Papillary renal cell carcinoma: current and controversial issues

Current Opinion in Urology, 2022
Purpose of the review Papillary renal cell carcinoma (pRCC) is the second most frequent renal cancer subtype and represents 15–20% of all RCC. Classification of pRCC is changing because novel tumour entities have been discovered in the last years.
Silvia Angori, J. Lobo, H. Moch
semanticscholar   +4 more sources

Clear cell and papillary renal cell carcinomas in hereditary papillary renal cell carcinoma (HPRCC) syndrome: a case report [PDF]

Diagnostic Pathology, 2021
Background Hereditary papillary renal cell carcinoma (HPRCC) is a rare autosomal dominant disease characterized by the development of multiple and bilateral papillary type I renal cell carcinomas (RCC) and papillary adenomas caused by activating ...
Sophie Ferlicot, Pierre-Alexandre Just, Eva Compérat, Etienne Rouleau, Frédérique Tissier, Christophe Vaessen, Stéphane Richard   +6 more
doaj   +5 more sources

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. [PDF]

New England Journal of Medicine, 2016
BACKGROUND Papillary renal-cell carcinoma, which accounts for 15 to 20% of renal-cell carcinomas, is a heterogeneous disease that consists of various types of renal cancer, including tumors with indolent, multifocal presentation and solitary tumors with ...
W. Linehan, P. Spellman, C. Ricketts, C. Creighton, S. Fei, Caleb F. Davis, D. Wheeler, Bradley A. Murray, L. Schmidt, C. Vocke, Myron Peto, A. A. M. Al Mamun, E. Shinbrot, A. Sethi, S. Brooks, W. Rathmell, Angela N. Brooks, K. Hoadley, A. G. Robertson, Denise Brooks, R. Bowlby, S. Sadeghi, Hui Shen, D. Weisenberger, Moiz Bootwalla, S. Baylin, P. Laird, A. Cherniack, G. Saksena, S. Haake, Jun Li, Han Liang, Yiling Lu, G. Mills, Rehan Akbani, Mark D. M. Leiserson, Benjamin J. Raphael, Pavana Anur, D. Bottaro, L. Albiges, N. Barnabas, T. Choueiri, B. Czerniak, A. Godwin, A. Hakimi, T. Ho, J. Hsieh, M. Ittmann, William Y. Kim, B. Krishnan, M. Merino, K. R. Mills Shaw, V. Reuter, Ed Reznik, C. Shelley, B. Shuch, S. Signoretti, R. Srinivasan, P. Tamboli, G. Thomas, S. Tickoo, K. Burnett, D. Crain, J. Gardner, Kevin R Lau, D. Mallery, S. Morris, J. Paulauskis, R. Penny, C. Shelton, W. T. Shelton, M. Sherman, E. Thompson, P. Yena, Melissa Avedon, Jay Bowen, J. Gastier-Foster, M. Gerken, K. Leraas, T. Lichtenberg, N. Ramirez, T. Santos, L. Wise, E. Zmuda, John A. Demchok, Ina Felau, C. Hutter, Margi Sheth, H. Sofia, R. Tarnuzzer, Zhining Wang, Liming Yang, J. Zenklusen, J. Zhang, Brenda Ayala, J. Baboud, Sudha Chudamani, Jia Liu, Laxmi Lolla, R. Naresh, T. Pihl, Qiang Sun, Yunhu Wan, Ye Wu, Adrian Ally, M. Balasundaram, S. Balu, R. Beroukhim, T. Bodenheimer, C. Buhay, Y. Butterfield, R. Carlsen, S. Carter, H. Chao, E. Chuah, A. Clarke, K. Covington, M. Dahdouli, N. Dewal, Noreen Dhalla, H. Doddapaneni, J. Drummond, S. Gabriel, R. Gibbs, R. Guin, Walker Hale, A. Hawes, D. Hayes, R. Holt, A. Hoyle, S. Jefferys, Steven J. M. Jones, Corbin D. Jones, D. Kalra, C. Kovar, L. Lewis, Jie Li, Yussanne Ma, M. Marra, Michael Mayo, S. Meng, M. Meyerson, P. Mieczkowski, Richard A. Moore, Donna Morton, Lisle E. Mose, A. Mungall, D. Muzny, J. Parker, C. Perou, J. Roach, J. Schein, S. Schumacher, Yan Shi, J. Simons, Payal Sipahimalani, Tara J. Skelly, Matthew G. Soloway, C. Sougnez, Angela Tam, Donghui Tan, N. Thiessen, Umadevi Veluvolu, Min Wang, M. Wilkerson, Tina Wong, Junyuan Wu, Liu Xi, Jane H. Zhou, Jason Bedford, Fengju Chen, Yao Fu, M. Gerstein, D. Haussler, K. Kasaian, Phillip H. Lai, Shiyun Ling, Amie Radenbaugh, D. J. Van Den Berg, J. Weinstein, Jingchun Zhu, Monique Albert, I. Alexopoulou, Jeremiah J. Andersen, J. Auman, J. Bartlett, S. Bastacky, Julie Bergsten, M. Blute, L. Boice, R. Bollag, J. Boyd, E. Castle, Ying-bei Chen, J. Cheville, Erin E. Curley, B. Davies, April DeVolk, R. Dhir, Laura Dike, J. Eckman, J. Engel, Jodi Harr, R. Hrebinko, Meijuan Huang, L. Huelsenbeck-Dill, M. Iacocca, B. Jacobs, M. Lobis, J. Maranchie, S. McMeekin, J. Myers, J. Nelson, J. Parfitt, A. Parwani, N. Petrelli, B. Rabeno, Somak Roy, A. Salner, J. Slaton, M. Stanton, R. Thompson, L. Thorne, Kelinda Tucker, P. Weinberger, C. Winemiller, L. A. Zach, R. Zuna   +227 more
semanticscholar   +5 more sources

Oncocytic papillary renal cell carcinoma (OPRCC): 2 case report and literature review [PDF]

Frontiers in Oncology
Oncocytic papillary renal cell carcinoma (OPRCC) is a new papillary renal cell carcinoma (OPRCC) added to the 2016 WHO Classification of Tumors of the Urinary and Male Reproductive System.
Yanchen Wang, Yanchen Wang, Lihui Guan, Lihui Guan, Yaming Liu, Yuxuan Liu, Xiaoyan Guo, Yaofei Sun, Yaofei Sun   +8 more
doaj   +2 more sources

A Review of Papillary Renal Cell Carcinoma and MET Inhibitors

Kidney Cancer, 2019
Papillary renal cell carcinoma (PRCC) is a subtype of renal cell carcinoma (RCC) accounting for approximately 15–20% of cases and further divided into Type 1 and Type 2.
Katherine E. Smith, Mehmet Asım Bilen
openalex   +3 more sources

PYCR1 is Associated with Papillary Renal Cell Carcinoma Progression

Open Medicine, 2019
Objective We aimed to determine the function of pyrroline-5-carboxylate reductase 1 (PYCR1) on progression of papillary renal cell carcinoma (PRCC) and related mechanism.
Qiuqin Wang, Ling Liu
semanticscholar   +5 more sources

Characterizing the outcomes of metastatic papillary renal cell carcinoma [PDF]

Cancer Medicine, 2017
Outcomes of metastatic papillary renal cell carcinoma (pRCC) patients are poorly characterized in the era of targeted therapy. A total of 5474 patients with metastatic renal cell carcinoma (mRCC) in the International mRCC Database Consortium (IMDC) were ...
J. Connor Wells, F. Donskov, A. Fraccon, F. Pasini, G. Bjarnason, B. Beuselinck, J. Knox, S. Rha, N. Agarwal, I. Bowman, Jae-Lyun Lee, S. Pal, S. Srinivas, D. Scott Ernst, U. Vaishampayan, L. Wood, R. Simpson, G. de Velasco, T. Choueiri, D. Heng   +19 more
semanticscholar   +5 more sources